CY2017014I1 - Φαρμακευτικοι συνδυασμοι που περιεχουν βενζοξαζινες για τη θεραπεια νοσων των αναπνευστικων οδων - Google Patents

Φαρμακευτικοι συνδυασμοι που περιεχουν βενζοξαζινες για τη θεραπεια νοσων των αναπνευστικων οδων

Info

Publication number: CY2017014I1
Authority: CY; Cyprus
Prior art keywords: treatment; compounds containing; respiratory tract; tract diseases; medicinal compounds
Prior art date: 2004-04-22

Application number

CY2017014C

Other languages

English (en)

Other versions

CY2017014I2 (el

Original Assignee

Boehringer Ingelheim International Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-04-22

Filing date

2017-04-20

Publication date

2017-11-14

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34966478&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY2017014(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2004-04-22 Priority claimed from DE102004019540A external-priority patent/DE102004019540A1/de

2004-11-03 Priority claimed from DE102004052987A external-priority patent/DE102004052987A1/de

2017-04-20 Application filed by Boehringer Ingelheim International Gmbh filed Critical Boehringer Ingelheim International Gmbh

2017-11-14 Publication of CY2017014I1 publication Critical patent/CY2017014I1/el

2017-11-14 Publication of CY2017014I2 publication Critical patent/CY2017014I2/el

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Epidemiology (AREA)
Pulmonology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Tropical Medicine & Parasitology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Endocrinology (AREA)
Dermatology (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Pain & Pain Management (AREA)
Reproductive Health (AREA)
Virology (AREA)
Rheumatology (AREA)
Transplantation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Medicinal Preparation (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

CY2017014C 2004-04-22 2017-04-20 Φαρμακευτικοι συνδυασμοι που περιεχουν βενζοξαζινες για τη θεραπεια νοσων των αναπνευστικων οδων CY2017014I2 (el)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
DE102004019540A DE102004019540A1 (de)	2004-04-22	2004-04-22	Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen
DE102004052987A DE102004052987A1 (de)	2004-11-03	2004-11-03	Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen
EP05002496		2005-02-07
PCT/EP2005/004073 WO2005102349A1 (de)	2004-04-22	2005-04-18	Arzneinmittelkombinationen enthaltend benzoxazine zur behandlung von atemwegserkrankungen
EP05739576A EP1781298B1 (de)	2004-04-22	2005-04-18	Arzneinmittelkombinationen enthaltend benzoxazine zur behandlung von atemwegserkrankungen

Publications (2)

Publication Number	Publication Date
CY2017014I1 true CY2017014I1 (el)	2017-11-14
CY2017014I2 CY2017014I2 (el)	2017-11-14

Family

ID=34966478

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
CY20121100308T CY1113890T1 (el)	2004-04-22	2012-03-26	Φαρμακευτικοι συνδυασμοι που περιεχουν βενζοξαζινες για τη θεραπεια νοσων των αναπνευστικων οδων
CY20141100925T CY1115719T1 (el)	2004-04-22	2014-11-07	Νεοι φαρμακευτικοι συνδυασμοι για τη θεραπεια νοσων των αναπνευστικων οδων
CY2017014C CY2017014I2 (el)	2004-04-22	2017-04-20	Φαρμακευτικοι συνδυασμοι που περιεχουν βενζοξαζινες για τη θεραπεια νοσων των αναπνευστικων οδων

Family Applications Before (2)

Application Number	Title	Priority Date	Filing Date
CY20121100308T CY1113890T1 (el)	2004-04-22	2012-03-26	Φαρμακευτικοι συνδυασμοι που περιεχουν βενζοξαζινες για τη θεραπεια νοσων των αναπνευστικων οδων
CY20141100925T CY1115719T1 (el)	2004-04-22	2014-11-07	Νεοι φαρμακευτικοι συνδυασμοι για τη θεραπεια νοσων των αναπνευστικων οδων

Country Status (33)

Country	Link
EP (2)	EP2422786B1 (el)
JP (1)	JP2007533683A (el)
KR (2)	KR20130049840A (el)
AR (1)	AR049262A1 (el)
AT (1)	ATE539754T1 (el)
AU (1)	AU2005235419B2 (el)
BE (1)	BE2015C065I2 (el)
BR (1)	BRPI0510080B8 (el)
CA (1)	CA2559699C (el)
CY (3)	CY1113890T1 (el)
DK (2)	DK2422786T3 (el)
EA (1)	EA013157B1 (el)
EC (1)	ECSP066947A (el)
ES (2)	ES2523518T3 (el)
FI (1)	FIC20170005I1 (el)
FR (1)	FR16C0029I2 (el)
HU (1)	HUS1500058I1 (el)
IL (2)	IL177685A (el)
LT (1)	LTC1781298I2 (el)
LU (1)	LU93066I2 (el)
MY (1)	MY148945A (el)
NL (1)	NL300779I2 (el)
NO (2)	NO337714B1 (el)
NZ (1)	NZ550797A (el)
PE (1)	PE20060462A1 (el)
PL (2)	PL2422786T3 (el)
PT (2)	PT2422786E (el)
SG (1)	SG152237A1 (el)
SI (2)	SI1781298T1 (el)
TW (2)	TWI374739B (el)
UY (1)	UY28861A1 (el)
WO (1)	WO2005102349A1 (el)
ZA (1)	ZA200606624B (el)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7056916B2 (en)	2002-11-15	2006-06-06	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Medicaments for the treatment of chronic obstructive pulmonary disease
DE102004024452A1 (de) *	2004-05-14	2005-12-08	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Aerosolformulierung für die Inhalation von Betaagonisten
US7220742B2 (en)	2004-05-14	2007-05-22	Boehringer Ingelheim International Gmbh	Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
US7923455B2 (en) *	2005-01-28	2011-04-12	Boehringer Ingelheim International Gmbh	Medicaments for the prevention or treatment of heart failure comprising administration of an anticholinergic
JP2008530177A (ja) *	2005-02-16	2008-08-07	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	抗コリン作用薬及びエチプレドノールを含有する医薬組成物
BRPI0614410A2 (pt)	2005-08-15	2011-03-29	Boehringer Ingelheim Int	processo para preparação de betamiméticos
TWI396541B (zh)	2005-10-10	2013-05-21	Boehringer Ingelheim Int	用於治療呼吸疾病之新穎藥物組合
US20070088030A1 (en) *	2005-10-10	2007-04-19	Barbara Niklaus-Humke	Aerosol formulations for the inhalation of beta-agonists
EP1948596B1 (en) *	2005-11-10	2011-10-19	Nicholas S. Bodor	Soft anticholinergic esters
JP2009526817A (ja) *	2006-02-16	2009-07-23	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	呼吸器疾患の治療用医薬組成物
DE502007006951D1 (de)	2006-08-07	2011-05-26	Boehringer Ingelheim Pharma	Arzneimittelkombinationen zur behandlung von atemwegserkrankungen
UY30543A1 (es) *	2006-08-18	2008-03-31	Boehringer Ingelheim Int	Formulacion de aerosol para la inhalacion de beta- agonistas
UY30542A1 (es) *	2006-08-18	2008-03-31	Boehringer Ingelheim Int	Formulacion de aerosol para la inhalacion de agonistas beta
EP2086641A2 (en) *	2006-10-26	2009-08-12	Boehringer Ingelheim International GmbH	Egfr kinase inhibitor combinations for the treatment of respiratory and gastrointestinal disorders
EP1921070A1 (de)	2006-11-10	2008-05-14	Boehringer Ingelheim Pharma GmbH & Co. KG	Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstelllung
WO2009098061A1 (de)	2008-02-07	2009-08-13	Boehringer Ingelheim International Gmbh	Spirocyclische heterocyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung
US8648191B2 (en)	2008-08-08	2014-02-11	Boehringer Ingelheim International Gmbh	Cyclohexyloxy substituted heterocycles, pharmaceutical compositions containing these compounds and processes for preparing them
US20120135969A1 (en) *	2008-11-27	2012-05-31	Boehringer Ingelheim International Gmbh	Novel powdered crystalline medicines for inhalation
WO2014016548A2 (en)	2012-07-27	2014-01-30	Cipla Limited	Pharmaceutical composition
EP2906218B1 (en)	2012-10-09	2016-12-14	Boehringer Ingelheim International GmbH	Beta-2-adrenoceptor agonist for the treatment of cough

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4460581A (en) *	1982-10-12	1984-07-17	Boehringer Ingelheim Kg	(1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones
US4570630A (en)	1983-08-03	1986-02-18	Miles Laboratories, Inc.	Medicament inhalation device
GB2178965B (en)	1985-07-30	1988-08-03	Glaxo Group Ltd	Devices for administering medicaments to patients
SE453566B (sv)	1986-03-07	1988-02-15	Draco Ab	Anordning vid pulverinhalatorer
SG45171A1 (en)	1990-03-21	1998-01-16	Boehringer Ingelheim Int	Atomising devices and methods
DE4318455A1 (de)	1993-06-03	1994-12-08	Boehringer Ingelheim Kg	Kapselhalterung
DE19536902A1 (de)	1995-10-04	1997-04-10	Boehringer Ingelheim Int	Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
EP1305300A1 (de) *	2000-04-27	2003-05-02	Boehringer Ingelheim Pharma GmbH & Co.KG	Neue, langwirksame betamimetika, verfahren zu deren herstellung und deren verwendung als arzneimittel
AP1572A (en)	2000-10-12	2006-02-13	Boehringer Ingelheim Pharma	Crystalline monohydrate, method for producing the same and use thereof in the production of a medicament.
PL208137B1 (pl)	2001-06-22	2011-03-31	Boehringer Ingelheim Pharma	Bezwodny krystaliczny bromek tiotropium, sposób jego wytwarzania i zastosowanie krystalicznego monohydratu bromku tiotropium do wytwarzania krystalicznego bezwodnego bromku tiotropium
DE10130371A1 (de) *	2001-06-23	2003-01-02	Boehringer Ingelheim Pharma	Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
ES2203327B1 (es) *	2002-06-21	2005-06-16	Almirall Prodesfarma, S.A.	Nuevos carbamatos de quinuclidina y composiciones farmaceuticas que los contienen.
DE10230751A1 (de) *	2002-07-09	2004-01-22	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue Arzneimittelkompositionen auf der Basis neuer Anticholinergika und EGFR-Kinase-Hemmern
DE10246374A1 (de) *	2002-10-04	2004-04-15	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue Betamimetika mit verlängerter Wirkungsdauer, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE10253282A1 (de) *	2002-11-15	2004-05-27	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung

2005
- 2005-04-18 DK DK11187038.2T patent/DK2422786T3/da active
- 2005-04-18 CA CA2559699A patent/CA2559699C/en not_active Expired - Fee Related
- 2005-04-18 ES ES11187038.2T patent/ES2523518T3/es not_active Expired - Lifetime
- 2005-04-18 JP JP2007508805A patent/JP2007533683A/ja active Pending
- 2005-04-18 PT PT111870382T patent/PT2422786E/pt unknown
- 2005-04-18 NZ NZ550797A patent/NZ550797A/en not_active IP Right Cessation
- 2005-04-18 WO PCT/EP2005/004073 patent/WO2005102349A1/de not_active Ceased
- 2005-04-18 ES ES05739576T patent/ES2380370T3/es not_active Expired - Lifetime
- 2005-04-18 SG SG200902525-5A patent/SG152237A1/en unknown
- 2005-04-18 EA EA200601846A patent/EA013157B1/ru active Protection Beyond IP Right Term
- 2005-04-18 SI SI200531488T patent/SI1781298T1/sl unknown
- 2005-04-18 DK DK05739576.6T patent/DK1781298T3/da active
- 2005-04-18 AU AU2005235419A patent/AU2005235419B2/en active Active
- 2005-04-18 PL PL11187038T patent/PL2422786T3/pl unknown
- 2005-04-18 EP EP11187038.2A patent/EP2422786B1/de not_active Expired - Lifetime
- 2005-04-18 KR KR1020137011141A patent/KR20130049840A/ko not_active Ceased
- 2005-04-18 KR KR1020067024528A patent/KR101287460B1/ko not_active Expired - Lifetime
- 2005-04-18 AT AT05739576T patent/ATE539754T1/de active
- 2005-04-18 EP EP05739576A patent/EP1781298B1/de not_active Expired - Lifetime
- 2005-04-18 SI SI200531904T patent/SI2422786T1/sl unknown
- 2005-04-18 PL PL05739576T patent/PL1781298T4/pl unknown
- 2005-04-18 BR BRPI0510080A patent/BRPI0510080B8/pt active IP Right Grant
- 2005-04-18 PT PT05739576T patent/PT1781298E/pt unknown
- 2005-04-19 UY UY28861A patent/UY28861A1/es not_active Application Discontinuation
- 2005-04-20 PE PE2005000432A patent/PE20060462A1/es active IP Right Grant
- 2005-04-20 MY MYPI20051739A patent/MY148945A/en unknown
- 2005-04-21 TW TW101108945A patent/TWI374739B/zh not_active IP Right Cessation
- 2005-04-21 TW TW094112735A patent/TWI372056B/zh active
- 2005-04-22 AR ARP050101601A patent/AR049262A1/es not_active Application Discontinuation
2006
- 2006-08-08 ZA ZA2006/06624A patent/ZA200606624B/en unknown
- 2006-08-24 IL IL177685A patent/IL177685A/en active IP Right Grant
- 2006-10-23 EC EC2006006947A patent/ECSP066947A/es unknown
- 2006-11-02 NO NO20065060A patent/NO337714B1/no active Protection Beyond IP Right Term
2012
- 2012-03-26 CY CY20121100308T patent/CY1113890T1/el unknown
2013
- 2013-05-26 IL IL226562A patent/IL226562A0/en unknown
2014
- 2014-11-07 CY CY20141100925T patent/CY1115719T1/el unknown
2015
- 2015-12-01 HU HUS1500058C patent/HUS1500058I1/hu unknown
- 2015-12-01 LT LTPA2015043C patent/LTC1781298I2/lt unknown
- 2015-12-01 NL NL300779C patent/NL300779I2/nl unknown
- 2015-12-01 BE BE2015C065C patent/BE2015C065I2/fr unknown
2016
- 2016-05-09 LU LU93066C patent/LU93066I2/fr unknown
- 2016-06-22 FR FR16C0029C patent/FR16C0029I2/fr active Active
- 2016-12-01 NO NO2016022C patent/NO2016022I1/no unknown
2017
- 2017-01-13 FI FIC20170005C patent/FIC20170005I1/fi unknown
- 2017-04-20 CY CY2017014C patent/CY2017014I2/el unknown

Also Published As

Publication number	Publication date
KR101287460B1 (ko)	2013-07-23
EP2422786B1 (de)	2014-08-13
AR049262A1 (es)	2006-07-12
KR20070015592A (ko)	2007-02-05
LTC1781298I2 (lt)	2018-09-25
EA013157B1 (ru)	2010-02-26
KR20130049840A (ko)	2013-05-14
BRPI0510080B8 (pt)	2021-05-25
NZ550797A (en)	2010-08-27
AU2005235419B2 (en)	2010-11-04
FR16C0029I1 (el)	2016-08-26
NO2016022I2 (no)	2016-12-01
BRPI0510080B1 (pt)	2020-08-18
EP1781298A1 (de)	2007-05-09
ZA200606624B (en)	2008-01-08
NO2016022I1 (no)	2016-12-01
TWI372056B (en)	2012-09-11
CA2559699A1 (en)	2005-11-03
NL300779I2 (nl)	2017-11-02
MY148945A (en)	2013-06-14
DK1781298T3 (da)	2012-05-07
SI1781298T1 (sl)	2012-04-30
PL1781298T4 (pl)	2017-07-31
AU2005235419A1 (en)	2005-11-03
ES2523518T3 (es)	2014-11-26
ATE539754T1 (de)	2012-01-15
FIC20170005I1 (fi)	2017-01-13
FR16C0029I2 (fr)	2017-01-27
UY28861A1 (es)	2005-11-30
BE2015C065I2 (el)	2024-08-08
CY1115719T1 (el)	2017-01-25
CA2559699C (en)	2012-06-19
PE20060462A1 (es)	2006-06-19
HUS1500058I1 (hu)	2016-01-28
PT2422786E (pt)	2014-11-12
LU93066I2 (fr)	2016-07-11
SG152237A1 (en)	2009-05-29
PL2422786T3 (pl)	2015-02-27
PT1781298E (pt)	2012-02-03
SI2422786T1 (sl)	2014-12-31
NO20065060L (no)	2006-11-21
IL177685A0 (en)	2006-12-31
TW201231055A (en)	2012-08-01
IL177685A (en)	2013-10-31
CY2017014I2 (el)	2017-11-14
TWI374739B (en)	2012-10-21
JP2007533683A (ja)	2007-11-22
BRPI0510080A (pt)	2007-10-16
NO337714B1 (no)	2016-06-06
DK2422786T3 (da)	2014-11-17
EP1781298B1 (de)	2012-01-04
EP2422786A1 (de)	2012-02-29
CY1113890T1 (el)	2016-07-27
ES2380370T3 (es)	2012-05-11
PL1781298T3 (pl)	2012-06-29
WO2005102349A1 (de)	2005-11-03
EA200601846A1 (ru)	2007-04-27
IL226562A0 (en)	2013-06-27
ECSP066947A (es)	2007-01-26

Publication	Publication Date	Title
CY2017014I2 (el)	2017-11-14	Φαρμακευτικοι συνδυασμοι που περιεχουν βενζοξαζινες για τη θεραπεια νοσων των αναπνευστικων οδων
CY2025003I2 (el)	2025-07-04	Λιποσωματα για τη χορηγηση φαρμακων συνθεσεις για τη θεραπευτικη αγωγη γαστρεντερικων διαταραχων
DK1656347T3 (da)	2011-01-10	Substituerede indolderivater til farmaceutisk sammensætning til behandling af luftvejssygdomme
HUE050998T2 (hu)	2021-01-28	Gyógyszerek fibrotikus betegségek kezelésére
EP2051760A4 (en)	2009-08-26	ADMINISTRATION OF ANTI-THERAPY
IL181049A0 (en)	2007-07-04	Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
CY2016040I2 (el)	2017-06-28	Επιλογες θεραπειας για τη νοσο του fabry
AP2037A (en)	2009-10-09	Use of substituted quinoline derivatives for the treatment of drug resistant mycobacterial diseases
DK1817282T3 (da)	2011-10-10	Til behandling af respiratoriske sygdomme egnede phenoxy derivater
DK1937633T3 (da)	2010-10-11	Biphenyloxyeddikesyrederivater til behandling af respiratoriske sygdomme
DK1778673T3 (da)	2010-03-01	Nye hydantoin-derivater til behandling af obstruktive luftvejssygdomme
PL1708991T3 (pl)	2008-02-29	Pochodne sulfonoamidu do leczenia chorób
CY2018006I1 (el)	2018-06-27	Θεραπευτικο σχημα κλαδριβινης για την θεραπευτικη αντιμετωπιση της σκληρυνσης κατα πλακας
ATE525355T1 (de)	2011-10-15	1-ä(4-äbenzoyl(methyl)aminoü-3- (phenyl)butylüazetidinderivate zur behandlung von gastrointestinalen erkrankungen 1
DK1940409T3 (da)	2010-11-29	Nye lægemiddelkombinationer til behandling af åndedrætssygdomme
DK1962869T3 (da)	2013-06-24	Behandling af luftvejssygdomme
NO20054180D0 (no)	2005-09-08	Behandling av bakterielle sykdommer i andedrettsorganene ved lokal tilforsel av fluorkinoloner
FR2873294B1 (fr)	2008-05-09	Association de medicaments
DK1856070T3 (da)	2011-09-26	Nye lægemidler til behandling af luftvejssygdomme
SK3934U (sk)	2004-10-05	Farmaceutická kompozícia určená na ošetrenie nosnej dutiny
SE0400575D0 (sv)	2004-03-05	A novel pharmacentical composition for the treatment of skin conditions